-
European Journal of Preventive... Oct 2023
Topics: Humans; Atrial Fibrillation; Nurse's Role; Catheter Ablation
PubMed: 37253266
DOI: 10.1093/eurjpc/zwad184 -
Current Cardiology Reports Oct 2022Cancer-related mortality has significantly declined over the past several decades as a result of improved screening, diagnostics, and therapeutics. Although cancer... (Review)
Review
PURPOSE OF REVIEW
Cancer-related mortality has significantly declined over the past several decades as a result of improved screening, diagnostics, and therapeutics. Although cancer patients and survivors are living longer, there is increased risk of both short-term and long-term cardiovascular complications, including arrhythmia. In this review, we highlight the current evidence detailing the connections between atrial fibrillation and cancer, provide insight into the mechanisms driving this relationship, and share practical considerations for the management of atrial fibrillation in cancer patients and cancer survivors.
RECENT FINDINGS
Atrial fibrillation is an increasingly recognized condition among cancer patients, with epidemiological data showing increased incidence and worse outcomes in patients with cancer. Studies also describe a bidirectional relationship between cancer and atrial fibrillation, attributable in part to shared risk factors but also potentially due to shared biology. Cancer treatment-associated arrhythmia is an active area of investigation, with ongoing research to identify the mechanisms and pathophysiology behind this phenomenon. Furthermore, management of atrial fibrillation in patients with cancer presents unique challenges, particularly in management of anti-coagulation. Cancer patients have increased risk of developing atrial fibrillation due to the shared risk factors and biology of the two conditions. Moreover, various cancer therapeutics are known to be arrhythmogenic; however, mechanisms remain unclear. Further research is needed to better understand the pathophysiology of atrial fibrillation in cancer patient in order to establish prevention and treatment strategies specific to this population.
Topics: Anticoagulants; Atrial Fibrillation; Cancer Survivors; Humans; Neoplasms; Risk Factors
PubMed: 35976601
DOI: 10.1007/s11886-022-01769-3 -
JACC. Clinical Electrophysiology May 2021
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Humans; Physicians; Registries
PubMed: 34016389
DOI: 10.1016/j.jacep.2020.11.025 -
Heart Rhythm Jun 2021
Topics: Anticoagulants; Atrial Fibrillation; Humans; Stroke
PubMed: 33639297
DOI: 10.1016/j.hrthm.2021.02.019 -
Minerva Cardiology and Angiology Oct 2022Historically, regular exercise contributed to reduce the arrhythmic burden and improve cardiovascular outcomes in the general population. However, a heightened risk of... (Review)
Review
Historically, regular exercise contributed to reduce the arrhythmic burden and improve cardiovascular outcomes in the general population. However, a heightened risk of atrial fibrillation (AF) seems to occur mainly amongst endurance athletes. The exact mechanisms are not fully elucidated, but dynamic interactions between electro-anatomical changes induced by exercise, the autonomic system, variable triggers, along individual genetic predisposition are the main contributors to AF development in athletes. The type and training load of sports are also crucial in determining the arrhythmogenic milieu predisposing to AF insurgence and perpetuation. Moreover, a sex difference seems to influence an increased risk of AF only in men undergoing strenuous exercise, whereas women appear protected even during more vigorous training. In the absence of solid evidence, the advent of modern technologies could help to monitor and deep investigate the peculiar aspects of AF in these athletes. This review aims to describe the pathophysiology, diagnosis, and management of AF in athletes, shedding light on possible future strategies to face AF in this population.
Topics: Athletes; Atrial Fibrillation; Exercise; Female; Heart; Humans; Male; Sports
PubMed: 35343173
DOI: 10.23736/S2724-5683.22.05842-2 -
International Journal of Cardiology Jan 2024Atrial fibrillation (AF) is the commonest sustained cardiac arrhythmia observed in clinical practice. Its prevalence increases dramatically with advancing age. This... (Review)
Review
Atrial fibrillation (AF) is the commonest sustained cardiac arrhythmia observed in clinical practice. Its prevalence increases dramatically with advancing age. This review article discusses the recent advances in studies investigating the relationship between aging and AF and the possible underlying mechanisms.
Topics: Humans; Atrial Fibrillation; Aging
PubMed: 37848123
DOI: 10.1016/j.ijcard.2023.131445 -
Europace : European Pacing,... Feb 2023
Topics: Humans; Atrial Fibrillation; Heart Failure
PubMed: 36576343
DOI: 10.1093/europace/euac255 -
Future Cardiology Mar 2020Silent atrial fibrillation (AF) is an asymptomatic atrial arrhythmia that can be diagnosed by chance during a systematic electrocardiogram, an external Holter, or from... (Review)
Review
Silent atrial fibrillation (AF) is an asymptomatic atrial arrhythmia that can be diagnosed by chance during a systematic electrocardiogram, an external Holter, or from implanted cardiac devices. There is a significant body of the literature around silent AF, yet it remains largely underdiagnosed in everyday clinical practice. Meanwhile, new diagnostic tools have significantly improved the detection of silent AF, creating a potential for mass screening via new technologies and the promise of a major step forward in e-health progress. However, it is not yet known whether silent AF is associated with the same thromboembolic risk as symptomatic AF, and whether these asymptomatic and often short-lasting episodes therefore require anticoagulation therapy and rhythm management.
Topics: Asymptomatic Diseases; Atrial Fibrillation; Disease Management; Electrocardiography, Ambulatory; Humans; Thromboembolism
PubMed: 32125174
DOI: 10.2217/fca-2019-0066 -
Journal of the American College of... Jan 2024
Topics: Humans; Atrial Fibrillation; Anticoagulants; Stroke; Guideline Adherence
PubMed: 38043044
DOI: 10.1016/j.jacc.2023.10.021 -
Clinical Obstetrics and Gynecology Dec 2020The prevalence of arrhythmias in pregnant women are rising, particularly among women with a history of structural heart disease or prior arrhythmia. The physiological...
The prevalence of arrhythmias in pregnant women are rising, particularly among women with a history of structural heart disease or prior arrhythmia. The physiological changes of pregnancy increase the risk of both benign and pathologic arrhythmias, with atrial fibrillation representing the most common pathologic arrhythmia. While bradyarrhythmias rarely require treatment during pregnancy, pharmacotherapy is frequently required for tachyarrhythmias. Electrophysiological procedures including cardioversions, ablations, and device placement are occasionally required during pregnancy and can be performed safely with proper precautions. This chapter will discuss the diagnosis and management of a broad array of cardiac arrhythmias that may be encountered in pregnant women.
Topics: Atrial Fibrillation; Female; Heart Diseases; Humans; Pregnancy
PubMed: 33136827
DOI: 10.1097/GRF.0000000000000567